| Hazard Information | Back Directory | [Uses]
Pegnivacogin is a novel RNA-aptamer based factor IXa inhibitor featuring a reversal agent, anivamersen. | [References]
[1] Staudacher DL, Putz V, Heger L, et al. Direct factor IXa inhibition with the RNA-aptamer pegnivacogin reduces platelet reactivity in vitro and residual platelet aggregation in patients with acute coronary syndromes.?Eur Heart J Acute Cardiovasc Care. 2019;8(6):520-526. doi:10.1177/2048872617703065 DOI:10.1177/2048872617703065 |
|
|